Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.88B |
| 2 |
Pfizer
PFE
|
+$1.41B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.17B |
| 4 |
Cisco
CSCO
|
+$1.1B |
| 5 |
Novartis
NVS
|
+$984M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.21B |
| 2 |
Adobe
ADBE
|
+$1.06B |
| 3 |
Stryker
SYK
|
+$955M |
| 4 |
Boston Scientific
BSX
|
+$695M |
| 5 |
Banco Santander
SAN
|
+$684M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.16% |
| 2 | Financials | 17.3% |
| 3 | Industrials | 10.45% |
| 4 | Healthcare | 9.91% |
| 5 | Energy | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
iShares MSCI Spain ETF
EWP
$2.11B
| $717K | ﹤0.01% |
13,211
-2,231
| -14% | -$123K |
|
727
Invesco S&P 500 Quality ETF
SPHQ
$19.4B
| $713K | ﹤0.01% |
+9,477
| New | +$737K |
|
728
Fidelity MSCI Health Care Index ETF
FHLC
$3.28B
| $710K | ﹤0.01% |
10,091
-311
| -3% | -$22.9K |
|
729
Amphenol
APH
$198B
| $705K | ﹤0.01% |
5,576
-164
| -3% | -$23.1K |
|
730
FedEx
FDX
$72.7B
| $700K | ﹤0.01% |
1,966
-1,101
| -36% | -$382K |
|
731
iShares Core MSCI Total International Stock ETF
IXUS
$58.3B
| $700K | ﹤0.01% |
+8,074
| New | +$719K |
|
732
Vanguard Real Estate ETF
VNQ
$39.2B
| $698K | ﹤0.01% |
7,864
-1,450
| -16% | -$133K |
|
733
Allstate
ALL
$68B
| $692K | ﹤0.01% |
3,338
+757
| +29% | +$155K |
|
734
Constellation Energy
CEG
$93.8B
| $686K | ﹤0.01% |
2,457
-311
| -11% | -$94.5K |
|
735
WisdomTree US LargeCap Dividend Fund
DLN
$6.26B
| $683K | ﹤0.01% |
+7,641
| New | +$695K |
|
736
Cheniere Energy
LNG
$55.2B
| $680K | ﹤0.01% |
2,394
+218
| +10% | +$50.3K |
|
737
Vanguard Health Care ETF
VHT
$18.1B
| $678K | ﹤0.01% |
2,489
+193
| +8% | +$55.2K |
|
|
PENG
738
Penguin Solutions Inc
PENG
$2.7B
| $677K | ﹤0.01% |
38,488
+1,889
| +5% | +$35.9K |
|
739
Vanguard S&P 500 Growth ETF
VOOG
$25.9B
| $664K | ﹤0.01% |
9,762
-72
| -0.7% | -$5.21K |
|
740
Mondelez International
MDLZ
$79.5B
| $664K | ﹤0.01% |
11,513
-2,287
| -17% | -$132K |
|
741
Seneca Foods Class A
SENEA
$1.12B
| $658K | ﹤0.01% |
+4,352
| New | +$562K |
|
742
Genpact
G
$5.96B
| $647K | ﹤0.01% |
17,368
-236
| -1% | -$9.72K |
|
743
Camden Property Trust
CPT
$11B
| $635K | ﹤0.01% |
6,503
+2,765
| +74% | +$293K |
|
744
JPMorgan US Quality Factor ETF
JQUA
$8.21B
| $634K | ﹤0.01% |
+10,344
| New | +$657K |
|
745
Las Vegas Sands
LVS
$31.7B
| $633K | ﹤0.01% |
11,754
-1,615
| -12% | -$91.9K |
|
746
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.2B
| $627K | ﹤0.01% |
+2,437
| New | +$669K |
|
747
Royal Caribbean
RCL
$85.1B
| $625K | ﹤0.01% |
2,272
+552
| +32% | +$164K |
|
748
BJs Wholesale Club
BJ
$12.5B
| $624K | ﹤0.01% |
6,338
+15
| +0.2% | +$1.45K |
|
749
Dick's Sporting Goods
DKS
$17.5B
| $621K | ﹤0.01% |
3,132
-12,248
| -80% | -$2.49M |
|
750
Schwab Emerging Markets Equity ETF
SCHE
$12.6B
| $619K | ﹤0.01% |
18,797
+10,745
| +133% | +$367K |
|
Similar funds
Ken Fisher's Q1 2026 Portfolio in Review
As of Q1 2026, Ken Fisher held 1,133 positions worth $295B, up 0.65% from $293B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Fisher's Q1 2026 filing shows 116 new, 416 increased, 461 reduced and 117 closed positions. Its largest new stake was Portfolio Building Block World Pharma and Biotech Index ETF: 28,040,859 shares worth $717M. The largest sale was Abbott, an estimated $1.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- Ken Fisher's largest Q1 2026 buy was Portfolio Building Block World Pharma and Biotech Index ETF: 28,040,859 shares worth $717M.
- Ken Fisher added most to AbbVie in Q1 2026, an estimated $1.88B increase.
- Ken Fisher's biggest Q1 2026 reduction was Abbott, cutting an estimated $1.21B.
- Ken Fisher fully exited Trip.com Group in Q1 2026, selling an estimated $175M.
- Ken Fisher's ten largest holdings make up 33% of its $295B portfolio in Q1 2026.
- Ken Fisher opened 116 new positions and closed 117 in Q1 2026.
- Ken Fisher's portfolio value rose 0.65% quarter-over-quarter to $295B.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.